Skip to main content

The Science Behind Exosomes: How Your Skin’s Cellular Messaging System Works

16.01.2026 | Skincare

Exosomes are one of the most talked-about ingredients in skincare right now. But most of the conversation stops at “they send signals to your cells.” If you have ever read a product description, a beauty editorial, or even a dermatologist’s explainer and walked away thinking you still do not fully understand what exosomes actually are or how they actually work, this article is for you. The question of how do exosomes work in skincare is one that deserves a real answer, not a metaphor dressed up as science.

Here is the plain version: exosomes are nano-sized biological vesicles, produced naturally by living cells, that carry molecular cargo from one cell to another. They coordinate skin renewal, repair, and regeneration. They are, in the clearest possible terms, your skin’s cellular messaging system. But that single sentence barely scratches the surface of what makes them biologically remarkable.

This article goes deep. By the end, you will understand how exosomes are physically constructed at a molecular level, how cells manufacture and “write” them through a process called biogenesis, how a target cell receives and reads the message, why a plant-derived exosome can meaningfully communicate with a human skin cell despite hundreds of millions of years of evolutionary distance, and where this science is heading. Exosomes explained, properly, from the inside out.

If you want the full product guide and routine advice, start with our complete exosome guide. This article goes further into the biology.


Inside the Envelope: What Exosomes Are Actually Made Of

Most people who have heard of exosomes know they are “tiny.” The standard descriptor is “nano-sized vesicles,” and while technically accurate, it does not convey just how structurally sophisticated these particles are. Understanding what exosomes are made of is the foundation for understanding everything else about them.

Exosomes range from 30 to 150 nanometres in diameter. For context, a single red blood cell is roughly 7,000 nanometres wide. A human pore is approximately 50,000 nanometres across. To put that in INKEY’s own terms: three million Cica-derived exosomes fit into a single bottle of the Exosome HydroGlow Complex, and each one is around 300 times smaller than a pore. These are not small molecules. They are fully enclosed biological structures, with all the architectural complexity that implies.

The Lipid Bilayer: The Envelope That Makes Everything Possible

The outer shell of an exosome is a phospholipid bilayer, structurally identical to the membrane of the cell it originated from. This is not incidental. It is the reason exosomes are biocompatible by default. The lipid bilayer is not a random assortment of fats. It is specifically enriched with sphingomyelin and cholesterol, two lipids that give the exosome membrane its distinctive rigidity and stability. Cholesterol, in particular, keeps the membrane ordered and resistant to disruption, which is part of why exosomes can survive in extracellular environments long enough to reach their targets.

This structural stability is also what distinguishes exosomes from simpler lipid particles. They are not passive droplets. They are enclosed, protected environments capable of shielding their molecular cargo from enzymatic degradation while in transit.

Surface Proteins: The Address on the Envelope

If the lipid bilayer is the envelope, then the proteins embedded in its outer surface are the address. Exosomes carry a characteristic set of surface proteins that serve two critical functions: identification and targeting.

The signature proteins are a family called tetraspanins, specifically CD9, CD63, and CD81. These proteins are so consistently present on exosomes that they are used as molecular markers to confirm a particle is genuinely an exosome in research settings. But their role is functional, not merely identifying: tetraspanins organise the surface of the exosome into specific microdomains that influence how the vesicle docks with target cells.

Beyond tetraspanins, integrins on the exosome surface determine tissue targeting with remarkable precision. Different integrin combinations direct exosomes toward different organs, tissues, and cell types. This is how exosomes “know” where to go. The surface protein profile is not random. It reflects the identity of the cell that produced the exosome and encodes information about where that exosome’s message is intended to be delivered.

The Cargo: Where the Real Intelligence Lives

The surface structure of an exosome is impressive. But the cargo is where the biological intelligence genuinely resides. Research published in the National Centre for Biotechnology Information confirms that exosomes carry a complex and varied molecular payload, including:

  • mRNA (messenger RNA): genetic instructions that the recipient cell can translate into new proteins
  • miRNA (microRNA): short regulatory sequences, typically 20 to 22 nucleotides long, that can switch specific genes on or off in the target cell
  • Proteins and enzymes: including growth factors such as TGF-beta and VEGF, which drive collagen synthesis, vascularisation, and tissue repair
  • Lipids: that can integrate into and alter the membrane composition of the target cell
  • Metabolites: small molecules that affect cellular energy pathways and metabolic signalling

Here is the point that matters most: this cargo is not random. Cells do not simply dump their contents into exosomes. They selectively sort and load specific molecular cargo depending on their current physiological state. A skin cell under UV stress loads very different cargo than a well-hydrated, resting cell. A fibroblast producing new collagen communicates different instructions than one in a state of inflammatory activation. The cargo is intentional. The message has meaning.

This brings us cleanly to the “text message” analogy that runs through exosome science. If an exosome is a biological message, its lipid bilayer is the envelope, its surface proteins are the address label, and its cargo is the message inside. Knowing that, the next logical question is: how does a cell decide what to write?

The answer takes us deep inside the cell, into a molecular machinery so intricate that it took decades of cell biology research to fully describe.


How Cells Write the Message: Exosome Biogenesis and the ESCRT Machinery

Understanding exosome biogenesis, the process by which cells actually create exosomes and decide what goes inside them, is what separates a genuine understanding of this technology from a surface-level one. This is the most differentiated section of this article. Very few places in the skincare world go here. But if you want to understand what makes an exosome an exosome rather than just another lipid nanoparticle, this is the section that answers it.

The Endosomal Pathway: Born Deep Inside the Cell

Exosomes do not form at the cell surface. They are not secreted directly from the cell membrane like many other signalling molecules. They are born deep within the cell, through a multi-stage process that begins with membrane folding and ends with release into the extracellular space.

The process starts when the outer cell membrane folds inward, forming cup-shaped structures called early endosomes. These are compartments the cell uses to process and sort incoming materials. Over time, early endosomes mature into late endosomes, a transition that involves significant molecular reorganisation. At this late endosome stage, something remarkable happens: the inner membrane of the late endosome begins to bud inward, forming smaller vesicles within the larger one. The late endosome is now a vesicle containing vesicles. In cell biology, this structure has a specific name: the multivesicular body, or MVB.

The small vesicles forming inside the MVB are called intraluminal vesicles, or ILVs. When the MVB eventually fuses with the plasma membrane, the outer boundary of the cell, and opens to the extracellular space, those ILVs are released. That release event is the moment of exosome birth. The ILVs, now free in the extracellular environment, are what we call exosomes.

The ESCRT Machinery: The Molecular Editor

The process described above raises an obvious question: what decides which molecules get packaged into the forming ILVs? The answer is one of the most elegant molecular systems in cell biology, the ESCRT machinery: Endosomal Sorting Complexes Required for Transport.

The ESCRT system operates as a sequential, four-complex assembly line that selects cargo and physically sculpts the forming vesicle. Research published in Nature on the molecular mechanisms of multivesicular body biogenesis provides the definitive account of how these complexes work together:

  1. ESCRT-0 recognises and clusters ubiquitinated proteins on the endosomal membrane. Ubiquitin is a molecular tag that flags cargo for inclusion. ESCRT-0 is the cell’s initial sorting decision: these are the molecules going into this exosome.

  2. ESCRT-I and ESCRT-II work together to initiate the inward deformation of the membrane around the flagged cargo, beginning the physical process of vesicle formation.

  3. ESCRT-III takes over to constrict and ultimately sever the neck of the forming vesicle, completing the ILV. This is the molecular equivalent of sealing the envelope.

  4. VPS4, an ATP-powered enzyme, disassembles ESCRT-III after the vesicle has been completed, recycling its components for the next round of vesicle formation.

The ESCRT system also works alongside alternative, ESCRT-independent pathways. Ceramide-dependent budding occurs when sphingomyelinase generates ceramide in the endosomal membrane, creating regions of membrane curvature that drive spontaneous vesicle budding. Tetraspanin-enriched microdomains, clusters of the same CD9 and CD63 proteins we saw on the exosome surface, can also organise cargo independently of ESCRT machinery.

The selective cargo loading of exosomes is not a passive process. It is a regulated, cell-state-dependent communication event.

Extending the text message analogy fully: ESCRT-0 is the cell deciding what it wants to say. ESCRT-I and II are drafting the message. ESCRT-III is pressing send. VPS4 is clearing the outbox.

Why This Matters for Topically Applied Exosomes

This mechanistic understanding has a direct implication for skincare. Plant-derived exosomes used in topical formulas, including the Cica Exosomes in our complete exosome guide, arrive at the skin pre-loaded. Their cargo was selected by ESCRT machinery in the plant source cells, under conditions specific to Centella Asiatica. When those exosomes are applied to skin, you are not introducing empty delivery vehicles. You are introducing exosomes that have already “written” a specific message based on the biological state of the cells that made them.

In INKEY’s case, that message is loaded with cargo consistent with Centella Asiatica’s centuries-long heritage in wound healing and skin repair: miRNAs and proteins associated with collagen synthesis signalling and inflammatory pathway suppression. The MDPI research on exosomes in a cosmetics context provides useful framing for understanding how this cargo profile translates to topical application. And if you have encountered claims about exosomes that seem too good to be true, 5 Exosome Skincare Myths Debunked is worth reading alongside this article.

The message has been composed and sealed. Now it needs to reach its destination and be read. How does a target skin cell actually receive an exosome?


How the Message Is Received: Exosome Uptake and Cell Signalling

Once an exosome has been released into the extracellular space, it faces its next challenge: reaching the right cell and delivering its cargo. This is where the third act of the cellular text message story plays out. Understanding how do exosomes work at the point of delivery reveals why this system is so much more targeted than simply applying a growth factor or peptide topically.

PMC research on exosome uptake mechanisms and dermatology identifies three primary pathways by which a target cell can receive an exosome’s cargo. Each mechanism is distinct in its kinetics, its specificity, and its downstream effects.

Three Ways a Cell Opens the Message

Direct membrane fusion is the fastest and most immediate pathway. In this mechanism, the lipid bilayer of the exosome merges directly with the plasma membrane of the target cell. Because both are phospholipid bilayers, they are structurally compatible and can fuse under the right conditions. When this happens, the exosome’s cargo is released immediately into the cytoplasm of the recipient cell. There is no intermediate processing. The message goes directly to the cell’s interior.

Endocytosis is the most common uptake route and involves the target cell actively engulfing the exosome. The cell membrane curves around the incoming exosome and pinches off, forming an internal vesicle. This can occur via several sub-mechanisms, including clathrin-mediated endocytosis, macropinocytosis, and phagocytosis, depending on the cell type and context. Unlike direct fusion, endocytosis places the exosome inside an endosomal compartment within the cell. The cargo is then released as the compartment matures and its contents are processed.

Receptor-ligand signalling is the most targeted mechanism of all, and arguably the most sophisticated. In this pathway, surface proteins on the exosome bind to specific receptor proteins on the target cell without the exosome being internalised at all. The binding event itself is sufficient to trigger a signalling cascade inside the recipient cell. The exosome acts as a key, and the receptor is the lock. Turning the lock changes the cell’s behaviour without the message ever needing to enter the room.

Extending the analogy: direct membrane fusion is like someone reading a message aloud as it arrives. Endocytosis is like opening it in a secure internal inbox and processing it there. Receptor-ligand signalling is like receiving a notification on your phone that changes your plans for the day without you ever reading the full message.

What Happens After Uptake: The Downstream Signalling Cascade

Once cargo enters the recipient cell by any of these mechanisms, the consequences are downstream, measurable, and biologically significant. A comprehensive review in the Journal of Clinical and Aesthetic Dermatology details these effects in a clinical context. The key pathways triggered include:

  • mRNA cargo from the exosome can be translated directly into new proteins by the recipient cell’s ribosomes, essentially giving the cell new genetic instructions
  • miRNA cargo integrates into the recipient cell’s gene regulation machinery, silencing specific transcripts and downregulating unwanted gene expression
  • Growth factor proteins in the cargo activate surface receptors that initiate downstream pathways: MAPK signalling, PI3K/Akt activation, and JAK-STAT cascades that collectively drive cell proliferation, survival, and differentiation

In the specific context of skin biology, this has concrete implications. When fibroblasts, the cells responsible for producing collagen and other structural proteins, take up exosomes carrying collagen-stimulating cargo, those fibroblasts genuinely upregulate collagen gene expression. The in vitro data for INKEY’s Cica Exosomes shows approximately a 300% increase in collagen-related gene expression, a figure that reflects this precise biological mechanism, not a marketing extrapolation.

Similarly, when keratinocytes or resident immune cells take up exosomes carrying anti-inflammatory miRNA cargo, pro-inflammatory gene expression is measurably downregulated. The 55% reduction in pro-inflammatory markers observed in vitro is the downstream consequence of exactly this signalling dynamic.

The Importance of Selectivity

One more thing is worth stating plainly: not every cell takes up every exosome. The surface protein profile of an exosome, particularly its integrin and tetraspanin composition, acts as both the address and the key. Only cells expressing the complementary receptor proteins will engage meaningfully with a given exosome. This selectivity is part of why exosome-mediated communication is fundamentally more targeted than applying a free protein growth factor topically, which broadcasts to every cell it contacts regardless of context.

Everything covered so far describes exosome communication within the same biological kingdom: cell to cell, human to human. But INKEY’s exosomes are plant-derived. That raises an obvious and legitimate question: why would a message written in a Centella Asiatica plant cell be readable by a human skin cell at all?


Cross-Kingdom Communication: Why Plant Exosomes Can Talk to Human Skin

This is the most scientifically remarkable section of this article, and one of the most underexplored topics in public-facing skincare science. The biology of cross-kingdom exosome communication is genuinely fascinating, and the intellectual honesty required to present it accurately is itself part of what makes this story compelling.

The Apparent Paradox

Centella Asiatica is a flowering plant with roots in Ayurvedic and traditional Asian medicine. Homo sapiens is a mammal. Between the evolution of plants and the evolution of humans lie hundreds of millions of years of separate evolutionary history. How, then, can a vesicle produced by a Cica plant cell carry cargo that a human fibroblast can interpret, respond to, and act upon?

The answer is not that evolution does not matter. It is that certain biological systems are so fundamental, so indispensable to the basic operation of living cells, that evolution has conserved them across the deep divide between kingdoms. The same molecular grammar that a plant cell uses to regulate stress response, manage inflammation, and coordinate repair is, in critical ways, the same grammar a human skin cell uses.

The Conserved Biology That Makes It Possible

Three overlapping mechanisms explain cross-kingdom exosome compatibility:

Conserved lipid bilayer structure is the most basic. The fundamental phospholipid bilayer architecture of cellular membranes is universal across eukaryotic life. Whether a membrane belongs to a Centella Asiatica leaf cell or a human dermal fibroblast, it is built from the same class of phospholipid molecules arranged in the same bilayer configuration. This means the “envelope” of a plant exosome is chemically legible to a human cell. The membrane can fuse. Endocytosis can occur. The physical uptake mechanisms described in the previous section are available to both plant and animal-derived exosomes.

Conserved signalling pathways go deeper. Many of the most fundamental cellular signalling cascades, including the MAPK pathways, PI3K-related signalling, and inflammatory regulators such as the NRF2 pathway, are evolutionarily ancient. They predate the divergence of plants and animals. A signalling molecule or miRNA that activates the NRF2 antioxidant response in a plant cell under oxidative stress may interact with functionally related machinery in a human skin cell, because the underlying molecular architecture was established before these life forms went their separate evolutionary ways.

Plant miRNA in human cells is perhaps the most striking evidence of cross-kingdom communication. Research has directly confirmed that plant-derived miRNAs can enter human cells, resist degradation, and influence gene expression. This was first reported for rice miRNAs in human plasma, and subsequent work has extended the finding to multiple plant species and human cell types.

The Research Behind Plant Exosome-Skin Interactions

The evidence for plant-derived exosome activity in human skin cells is accumulating rapidly. Key findings include:

  • Research published in PubMed on kale-derived exosome-like nanovesicles demonstrated enhanced type I collagen production in human dermal fibroblasts, mediated by the delivery of plant miRNAs that downregulate Smad7, a known inhibitor of collagen synthesis signalling
  • Plant nanovesicles have been shown to modulate IL-17 and NRF2 pathways in human skin cells, producing measurable reductions in inflammatory markers
  • Lemon-derived nanovesicles reduce reactive oxygen species in human fibroblasts via AhR/Nrf2 activation, a pathway central to the skin’s antioxidant defence
  • MDPI research on plant-derived exosomes as cross-kingdom regulators provides a comprehensive framework for understanding how this communication occurs at a molecular level

National Geographic’s analysis of exosome skincare also situates this research within the broader context of how the field is developing, offering useful perspective on where scientific consensus currently sits.

The Cica Exosome Specifically

Centella Asiatica’s documented biological properties, its centuries-long use in wound healing, its recognised anti-inflammatory profile, and its role in traditional skin repair preparations, are not coincidental. The plant’s cells produce exosomes consistent with those functional properties. When those exosomes are cultivated under controlled laboratory conditions using sustainable tissue cultures, the cargo they carry reflects the biological state of healthy, actively stress-responding Cica cells. The result is a plant-derived exosome with a specific, characterised cargo profile rather than a generic nanovesicle with uncharacterised contents.

An Honest Acknowledgement

The science here deserves to be presented accurately. Research into cross-kingdom plant exosome communication is genuinely compelling and increasingly well-supported. It is not, however, complete. Not every plant miRNA translates seamlessly into every human signalling pathway. The degree of uptake, the stability of plant exosomes on the skin surface, and the concentration required for meaningful biological effect are all active areas of investigation. The validated mechanisms are real. The in vitro data is meaningful. The field is also still developing, and intellectual honesty demands acknowledging that alongside the excitement.

That acknowledgement is itself consistent with how INKEY thinks about science: not as a closed book of certainties, but as an ongoing conversation between evidence and understanding. If you want to separate the established science from the more speculative claims in the broader exosome market, 5 Exosome Skincare Myths Debunked is designed precisely for that purpose.

The biology is remarkable. But what does it actually mean when you look in the mirror?


From Mechanism to Measurable Outcome: What This Science Does for Your Skin

This section is deliberately short. The science in the preceding four sections is the “why.” What follows is the “what,” connecting each mechanism to a specific, measured outcome. For the complete benefits breakdown, skin type guidance, and routine integration advice, our complete exosome guide is the right place to go.

Each of the mechanisms described in this article produces a specific, traceable result in skin biology.

The ESCRT-mediated cargo sorting process, which loads collagen-stimulating growth factors and miRNAs into Cica Exosomes, combined with the endocytic uptake of those exosomes by dermal fibroblasts, produces a measurable downstream effect on collagen gene expression. In vitro testing of INKEY’s Cica Exosomes shows approximately a 300% increase in genes related to collagen production. That is not a separate claim. It is the direct biological consequence of the mechanism described in sections two and three of this article. PMC research on wound healing and collagen synthesisprovides the broader mechanistic context for this effect.

Anti-inflammatory miRNA cargo, taken up via endocytosis and processed through the recipient cell’s gene regulation machinery, produces the 55% reduction in pro-inflammatory markers observed in vitro. The signalling cascade runs from exosome uptake through RNA-induced silencing complex activity to measurable downregulation of inflammatory gene expression. This is the mechanism of action.

The 63% increase in markers associated with skin renewal after eight hours of in vitro exposure reflects the rapid downstream activation of cellular renewal pathways triggered by exosome receptor-ligand interactions and cytoplasmic cargo release. Eight hours is fast, because receptor-ligand signalling does not require full endosomal processing to initiate a response.

Barrier-strengthening lipid cargo and Ectoin in the formula together support keratinocyte function and transepidermal water loss reduction, producing the clinically validated up to 12 hours of hydration measured in a clinical study of 31 people. PMC research on hydration outcomes in skincare supports the biological plausibility of this effect.

All of these outcomes are accessible in a single formula. The Exosome HydroGlow Complex is built around one percent plant-derived Cica Exosomes alongside Hyaluronic Acid, Ectoin, Kollaren peptide, Prickly Pear Extract, and Ubiquinone (Q10), delivering these mechanisms in a lightweight, creamy serum suitable for all skin types, morning and evening.

Exosome science as it stands today is already extraordinary. But what researchers are working on right now takes it considerably further.


The Frontier: Where Exosome Science Is Heading Next

One of the things that makes exosome science genuinely exciting, rather than merely trendy, is that the current state of knowledge represents a beginning. The mechanisms described in this article, the ESCRT machinery, the cross-kingdom miRNA transfer, the receptor-ligand selectivity, were largely unknown to science twenty years ago. The pace at which understanding has advanced suggests that the next twenty years will produce developments that are difficult to fully anticipate from where we stand today.

Engineered Exosomes: Writing a Specific Message

The most immediately compelling frontier in exosome science is the deliberate engineering of exosome cargo. Currently, exosomes used in skincare are naturally secreted: the cargo they carry reflects what the source cells happened to load during biogenesis. The next generation of research is asking whether that cargo can be intentionally programmed.

Researchers are exploring methods to load exosomes with targeted miRNAs and specific growth factors that would not naturally occur together in a secreted vesicle. The potential application is significant: bespoke exosome formulations designed for specific skin concerns, where the cargo profile is optimised for a particular outcome, whether that is collagen stimulation, hyperpigmentation suppression, barrier repair, or something else entirely. This is not yet a commercial reality. But the scientific infrastructure is being built, and it builds on exactly the ESCRT mechanisms and cargo sorting biology described earlier in this article.

Targeted Delivery: A Key for Every Lock

A second frontier involves engineering the surface proteins of exosomes to direct them toward specific cell populations. Currently, topically applied exosomes interact with whatever cells they encounter via the available uptake pathways. Future surface protein engineering could make exosomes that specifically target fibroblasts for collagen production, or melanocytes for pigmentation regulation, without broadly activating other cell types.

In practical terms, this could mean exosomes that do different things depending on which cells they reach, rather than delivering the same cargo broadly. It is a shift from general communication to precision messaging, made possible by a deeper understanding of the tetraspanin and integrin targeting systems described in Section 1.

Personalised Exosome Profiles

Perhaps the most speculative, but also the most intriguing, area of active research is the emerging understanding that exosome profiles differ between individuals. Age, skin condition, microbiome composition, and underlying genetic makeup all influence the types and quantities of exosomes a person’s cells naturally produce and receive. Early-stage research is beginning to characterise these individual exosome profiles, with the long-term goal of developing therapies tailored to a person’s specific cellular communication needs.

This is genuinely early work. The tools to characterise individual exosome profiles at scale are still being developed. But the direction of travel is clear, and it points toward a future where exosome-based interventions are as personalised as the cells that produce them.

Plant Exosome Research Is Accelerating

The cross-kingdom communication field described in Section 4 is not a settled science. It is an active and rapidly expanding area of research. Marie Claire UK’s coverage of exosomes as the biggest breakthrough in regenerative skincarecaptures the broader cultural momentum well, noting that what was once an in-clinic treatment is now reaching accessible at-home formulas. As more plant sources are systematically validated and their exosome cargo profiles characterised, skincare formulations will become increasingly sophisticated in how they select and use plant-derived starting materials.

WhoWhatWear UK’s analysis of whether exosomes are really the next big thing in skincare makes an important point: the exosome category arrived in the market faster than the clinical evidence could fully support it. That is a real and valid observation. It is also exactly why the distinction between scientifically grounded formulations and those making unsubstantiated claims matters. The scientific infrastructure being built in research labs and universities right now is what will determine which products deserve their position in the market. Exosomes in accessible skincare are the beginning of that trajectory. The brands investing in genuine evidence are the ones that will be validated as the science catches up to the category.

For a practical look at how exosome science is already being applied alongside other proven actives in your skincare routine, see how exosome science works synergistically with retinol.


The Message, Sent

If you started this article thinking of exosomes as a trending skincare ingredient, the hope is that you are leaving with a more complete picture. They are not a passive delivery system dressed up in scientific language. They are an active, selective, molecularly precise communication network. The ESCRT machinery that writes the message. The surface proteins that address it. The three distinct mechanisms by which a target cell opens and reads it. The conserved biology that allows a plant exosome to communicate meaningfully with a human skin cell. These are not marketing constructs. They are mechanisms, and they have been described with increasing precision by researchers across cell biology, molecular genetics, and dermatology for the better part of three decades.

The fact that this technology is accessible in a £20 serum is itself a statement about what democratised skincare can look like. Exosomes were once the exclusive territory of clinic treatments and high-end regenerative medicine. Making the science accessible, at a price that does not require a clinic appointment, reflects a particular view about who deserves effective skincare.

Science this interesting deserves more than a marketing claim. That is why INKEY chooses transparency over hype.


Ready to Explore Exosome Technology for Your Skin?

The science is remarkable. The starting point is simple.

Start with our complete guide to exosomes in skincare for the full breakdown of benefits, routine advice, and what to look for in a formula. Or go straight to the product that makes this science accessible: the Exosome HydroGlow Complex.

Related reading: